Reporting owner · Q3 2026 · CIK 1224091

Mahoney David L: insider trades.

Mahoney David L reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($12.3M), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
MAHONEY DAVID L

Companies

CompanyRelationshipTransactions
Corcept Therapeutics Inc (CORT)Director4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-18Corcept Therapeutics IncS91,167$118.241,140,994Form 4
2026-08-18Corcept Therapeutics IncS400$119.641,133,539Form 4
2026-08-18Corcept Therapeutics IncS7,055$118.881,133,939Form 4
2026-08-18Corcept Therapeutics IncS4,984$117.471,232,161Form 4

Questions

What stock did Mahoney David L buy or sell?

Mahoney David L reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($12.3M), across 1 company.

Is Mahoney David L the same person as other filers with this name?

This page covers SEC CIK 1224091 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/mahoney-david-l-1224091.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.